For Patients

Cancer Treatment Updates

Immunotherapy drug improves outcomes for some children with relapsed leukemia

December 10th, 2019

For children and young adults with certain relapsed B-cell acute lymphoblastic leukemia (B-ALL), the immunotherapy drug blinatumomab is superior to standard chemotherapy, an NCI-sponsored Children’s Oncology Group trial shows.

Read More

Study quantifies impact of NCI-sponsored trials on clinical cancer care

September 18th, 2019

Nearly half of phase 3 cancer clinical trials carried out by the NCI-sponsored SWOG Cancer Research Network were associated with clinical care guidelines or new drug approvals, a study in JAMA Network Open shows.

Read More

NCI study finds long-term increased risk of cancer death following common treatment for hyperthyroidism

July 1st, 2019

Findings from a new NCI study of patients who received radioactive iodine (RAI) treatment for hyperthyroidism show an association between the dose of treatment and long-term risk of death from solid cancers, including breast cancer.

Read More

Annual Report to the Nation: Overall cancer mortality continues to decline; Special section on adults ages 20 to 49 shows higher cancer incidence and mortality for women than men

May 30th, 2019

The 2019 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and cancer incidence dropped in men and remained stable in women. A special section reports on recent cancer trends in younger adults.

Read More

Study shows incidence rates of aggressive subtypes of uterine cancer rising

May 22nd, 2019

An NCI-led study shows rates for aggressive subtypes of uterine cancer rose rapidly among women ages 30 to 79 from 2000–2015. The findings, published in the Journal of Clinical Oncology, also reveal racial disparities in incidence and survival rates.

Read More

Harnessing T-cell “stemness” could enhance cancer immunotherapy

March 28th, 2019

A new study provides insight into how cancer immunotherapy works and suggests ways to enhance the treatment’s effectiveness. The NCI-led study, published in Science, examined the effect of high potassium levels on T cells.

Read More

Szent-Györgyi Prize to honor NCI’s Steven A. Rosenberg

February 12th, 2019

The 2019 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to NCI’s Steven A. Rosenberg, M.D., Ph.D., for his pioneering role in the development of immunotherapy.

Read More

AI approach outperformed human experts in identifying cervical precancer

January 10th, 2019

A research team from NIH and Global Good has developed a computer algorithm that can analyze digital images of the cervix and identify precancerous changes that require medical attention. The AI approach could be valuable in low-resource settings.

Read More

BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk

January 9th, 2019

The BRCA Exchange, a global resource that includes data on thousands of inherited variants in the BRCA1/BRCA2 genes, is available to the public through a website and new smartphone app.

Read More

BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk

January 9th, 2019

The BRCA Exchange, a global resource that includes data on thousands of inherited variants in the BRCA1/BRCA2 genes, is available to the public through a website and new smartphone app.

Read More

 1 2 3 >  Last ›